Collectively, all these data suggest that p53 could affect bone remodeling indirectly and contributing to higher bone intake, and thus abnormal p53 expression in cancer patients may regulate pathological bone remodeling and tumor progression through OPG. The gene discussed is TP53; the disease is neoplasm.